
When Jacob Glanville first spoke to Tim Friede, he said, "I'd love to get my hands on some of your blood."
As CEO of the biotech company Centivax, Glanville was developing a universal snakebite treatment. And Friede is a self-taught herpetologist with hyperimmunity to some of the world's deadliest snake toxins.